GlassScriptPhysician profile
Madalyn Brownlee
NPI 1962163691
$1,817.40
in general payments reported to CMS, 2019-2025
38 companies · $631 in 2025
The $631 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $459 · 2023: $325 · 2024: $403 · 2025: $631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,358.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $184.35 | 2022-2025 | Enhertu, Lynparza, Calquence |
| Novartis Pharmaceuticals Corporation | $124.40 | 2022-2025 | |
| Glaxosmithkline, LLC. | $114.89 | 2022-2025 | Zejula, Jemperli |
| Intuitive Surgical, INC. | $97.67 | 2022 | |
| Abbvie INC. | $93.67 | 2024-2025 | |
| Eisai INC. | $91.66 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $80.53 | 2024-2025 | Libtayo |
| Incyte Corporation | $70.30 | 2022-2025 | Jakafi, Monjuvi, Zynyz |
| Genzyme Corporation | $65.72 | 2022-2024 | |
| Janssen Biotech, INC. | $63.31 | 2023-2024 | Darzalex, Talvey, Tecvayli |
| Jazz Pharmaceuticals INC. | $58.82 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $58.69 | 2022-2025 | Iclusig |
| Daiichi Sankyo INC. | $43.27 | 2024-2025 | Enhertu, Datroway |
| Merck Sharp & Dohme LLC | $41.88 | 2025 | Keytruda, Keytruda Qlex, Welireg |
| Bayer Healthcare Pharmaceuticals INC. | $41.86 | 2023-2025 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madalyn Brownlee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.